The London Technology team advised Creandum on their lead investment into Lindus Health in connection with the company’s $18 million Series A round. Other investors included Peter Thiel and returning investors Seedcamp, Hambro Perks and Amino Collective.
Lindus Health provides a technology platform for health and biotech companies to execute clinical trials from start to finish.
The Goodwin team included Ella Donegan.
For additional details on the financing please read Lindus Health’s press release.